In-depth: How a Cape Town company made an mRNA vaccine and what happens next : vimarsana.com

Catherine Tomlinson takes an in-depth look at how Afrigen managed to reach this point and what further challenges have to be overcome before mRNA vaccines can be produced at scale in South Africa.

Related Keywords

Cape Town , Western Cape , South Africa , Argentina , Brazil , South African , Candice Sehoma , Afrigen Biologics , Sahpra Nthabi Moloi , Morena Makhoana , Petro Terblanche , Pfizer , National Regulatory Authority , African Health Products Regulatory Authority Sahpra , World Health Organization , Mrna Vaccine Technology Transfer Hub , University Of Witwatersrand Wits , Reuters , Cape Town Based , Transfer Hub , Good Manufacturing Practices , Good Manufacturing Practice , Medicines Act , Maturity Level , Nthabi Moloi , Drug Product , Formulation Fill Finish , Medicines Patent Pool , Cooperation Treaty , Sans Fronti , Technology Transfer Hub , ,